Brolucizumab 12-And 16-Week Fixed Dosing Potential in Neovascular Amd: A Post Hoc Evaluation of Data from the Hawk and Harrier Trials

AuthID
P-00X-11W
11
Author(s)
Singer, M
·
Khanani, AM
·
Wolf, A
·
Flores, R
·
Chhablani, J
·
Guruprasad, B
·
Clemens, A
·
Liu, XX
·
Document Type
Article
Year published
2022
Published
in OPHTHALMOLOGICA, ISSN: 0030-3755
Volume: 245, Issue: 4, Pages: 315-322 (8)
Indexing
Publication Identifiers
Pubmed: 35344964
Scopus: 2-s2.0-85135597067
Wos: WOS:000836226400002
Source Identifiers
ISSN: 0030-3755
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.